CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.
CVS Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for CVS, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that CVS HEALTH Corp ranked in the 71th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 159.17% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for CVS, they are:
As a business, CVS is generating more cash flow than 96.1% of positive cash flow stocks in the Healthcare.
53% of the company's capital comes from equity, which is greater than only 22.33% of stocks in our cash flow based forecasting set.
CVS HEALTH Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 1.83% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CVS, try ESMC, FTLF, ALXN, SGRY, and ENSG.
An pharmacy benefit management services is an instrument that conducts high-frequency alternating current through a patient's body that generates heat energy. Mostly, the devices are classified as monopolar or bipolar, which can be used for fulgurating tissue, cutting, coagulating or
A former Arkansas health official is sounding alarms about the pace of coronavirus vaccines being administered to residents of long-term care facilities under a U.S. plan that puts major pharmacy chains CVS and Walgreens in charge of many of the shots. Fewer than 10% of doses allocated to those Arkansas seniors have been administered, according to the state health department. The two pharmacies are working with about 40% of the state's facilities.
One key to unlocking the logjam of COVID-19 vaccines is in plain view but so far overlooked: the neighborhood retail pharmacy. As of Monday, 9 million people had received at least one dose of the Pfizer (PFE) or Moderna (MRNA) vaccines since they were approved in December. Pfizer’s vaccine must be stored at minus 70 degrees Celsius which complicates inoculation efforts that are not close to specialty freezers.
Many U.S. pharmacies, including those inside Kroger Co supermarkets and the drugstore chain of CVS Health Corp, say they will not be checking IDs before administering COVID-19 vaccines, leaving the door open to those who do not meet states' guidelines to jump the line. While the United States has distributed more than 30 million vaccine doses, a little over 11 million had been administered as of Thursday, a lag that prompted U.S. health secretary Alex Azar to call on states to begin vaccinating the vulnerable older population and those with certain chronic health conditions to get more vaccines into arms. U.S. retailers face a choice of strictly enforcing state eligibility rules with on-site identity checks, or rely on an honor system that could allow people to ignore those guidelines...